John L. Knopf, CEO and President at ACCELERON PHARMA INC (XLRN), sold 19,000 shares at $29.66 ($564K) on 2015-07-07, disclosed to the SEC on 2015-07-09.
Scheduled sale ($564k) by CEO and President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.66 | 17,600 | $522K | 92.5% |
| 2 | $30.25 | 1,400 | $42K | 7.5% |
| Total | $29.70 avg | 19,000 | $564K | 100% |
| Filing → |
| XLRN | SELL | 2016-05-20 | $3.3M | — | Filing → |
| XLRN | SELL | 2015-10-09 | $463K | — | Filing → |
| XLRN | SELL | 2015-09-10 | $574K | — | Filing → |